FAIR VALUE MEASUREMENTS AND INVESTMENTS (Tables)

12 Months Ended

Jan. 28, 2022

Fair Value Disclosures [Abstract]

Hierarchy for assets and liabilities measured at fair value on a recurring basis

The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the dates indicated:

	January 28, 2022								January 29, 2021
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs				Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	(in millions)
Assets:
Cash and cash equivalents:
Money market funds	$	3,737	$	—	$	—	$	3,737	$	5,109	$	—	$	—	$	5,109
Marketable equity and other securities	86		—		—		86		287		—		—		287
Derivative instruments	—		253		—		253		—		95		—		95
Total assets	$	3,823	$	253	$	—	$	4,076	$	5,396	$	95	$	—	$	5,491
Liabilities:
Derivative instruments	$	—	$	138	$	—	$	138	$	—	$	128	$	—	$	128
Total liabilities	$	—	$	138	$	—	$	138	$	—	$	128	$	—	$	128

Carrying value and estimated fair value of outstanding debt

Carrying Value and Estimated Fair Value of Outstanding Debt — The following table presents the carrying value and estimated fair value of the Company’s outstanding debt as described in Note 7 of the Notes to the Consolidated Financial Statements, including the current portion, as of the dates indicated:

	January 28, 2022				January 29, 2021
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(in billions)
Senior Secured Credit Facilities	$	—	$	—	$	6.2	$	6.3
Senior Notes	$	16.1	$	18.5	$	20.9	$	25.5
Legacy Notes and Debentures	$	0.8	$	1.1	$	1.2	$	1.6
EMC Notes	$	—	$	—	$	1.0	$	1.0

Investments

The following table presents the amortized cost, cumulative unrealized gains, cumulative unrealized losses, and carrying value of the Company's strategic investments in marketable and non-marketable equity securities as of the dates indicated.

	January 28, 2022								January 29, 2021
	Cost		Unrealized Gain		Unrealized Loss		Carrying Value		Cost		Unrealized Gain		Unrealized Loss		Carrying Value
	(in millions)
Marketable	$	126	$	79	$	(119)	$	86	$	185	$	144	$	(42)	$	287
Non-marketable	593		900		(52)		1,441		454		419		(11)		862
Total equity and other securities	$	719	$	979	$	(171)	$	1,527	$	639	$	563	$	(53)	$	1,149

Gain (loss) on securities

The following table presents unrealized gains and losses on marketable and non-marketable equity and other securities for the periods indicated:

	Fiscal Year Ended
	January 28, 2022		January 29, 2021		January 31, 2020
	(in millions)
Marketable securities
Unrealized gain	$	45	$	288	$	5
Unrealized loss	(151)		(45)		(18)
Net unrealized gain (loss)	(106)		243		(13)
Non-marketable securities
Unrealized gain	604		190		75
Unrealized loss	(43)		(59)		(15)
Net unrealized gain (a)	561		131		60
Total net gain on equity and other securities	$	455	$	374	$	47

____________________

(a)    For all periods presented, net gains on non-marketable securities are due to upward adjustments for observable price changes offset by losses primarily attributable to impairments.

The following table summarizes the Company’s debt securities for the periods indicated:

	January 28, 2022								January 29, 2021
	Amortized Cost		Unrealized Gains		Unrealized Loss		Carrying Value		Amortized Cost		Unrealized Gains		Unrealized Loss		Carrying Value
	(in millions)
Fixed income debt securities	$	333	$	26	$	(47)	$	312	$	176	$	12	$	(3)	$	185